Skip to main content
letter
. 2020 Jun 22;107(9):e314–e315. doi: 10.1002/bjs.11767

Table 1.

Patient characteristics

  Group 2 (2019) Group 1 (2020) P
Patients 122 106  
Age (σ) 64·7 (12·1) 66·8 (13·7) 0·22
Gender Male 69 (56·6%) 65 (61·3%) 0·47
  Female 53 (43·4%) 41 (38·7%)  
Charlson 5·7 (2·6) 5·3 (2·3) 0·32
BMI (σ) 26·4 (4·2) 27·3 (4·9) 0·13
Previous chemotherapy 22 (18%) 16 (15·1%) 0·55
Minimally invasive surgery Yes 72 (59%) 66 (62·3%) 0·68
  No 50 (41%) 40 (37·7%)  
Procedure Complexity      
Transurethral bladder cancer resection 2 21 (17·2%) 22 (20·8%) 0·34
Breast 2 25 (20·5%) 20 (18·9%)  
Colon 3 18 (14·8%) 15 (14·2%)  
Rectum 4 15 (12·3%) 9 (8·5%)  
Partial/total nephrectomy 3 9 (7·4%) 11 (10·4%)  
Radical prostatectomy 3 6 (4·9%) 7 (6·6%)  
Liver resection 4 11 (9%) 3 (2·8%)  
Pancreatectomy 4 4 (3·3%) 5 (4·7%)  
Carcinomatosis 4 2 (1·6%) 3 (2·8%)  
Orquiectomy / penile resection 2 2 (1·6%) 3 (2·8%)  
Gastrectomy 3 3 (2·5%) 2 (1·9%)  
Thyroidectomy 3 5 (4·1%) 1 (0·9%)  
Radical cystectomy 4 0 4 (3·8%)  
Esophagectomy 4 1 (0·8%) 0  
Soft tissue sarcoma 3 0 1 (0·4%)